Skip to main content

Nu Skin Enterprises, Inc.

NUS
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
SEC CIK
0001021561

No open-market purchases or sales by Nu Skin Enterprises, Inc. insiders were filed in the last 90 days; 162 institutions reported holding it in 13F filings for Q2 2026, worth $191.1M in total; no superinvestor holds it.

Holders of 5% or more of NUS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nu Skin Enterprises, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NUS
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A7.60%3.76M shares–Apr 17, 20251 filingApr 17, 2025SEC
Charles Schwab Investment Management Inc13G5.37%2.62M sharesNewFeb 12, 20261 filingFeb 12, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Nu Skin Enterprises, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NUS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Mar 27, 202611:06 AM ETVanguard Group Inc13G/A0.00%0 shares−7.92 ppfrom 7.92%Below 5%Mar 13, 2026SEC
Feb 12, 20263:19 PM ETCharles Schwab Investment Management Inc13G5.37%2.62M sharesNewDec 31, 2025SEC
Apr 17, 20259:35 AM ETBlackRock, Inc.13G/A7.60%3.76M shares–Mar 31, 2025SEC
Jan 31, 20259:56 AM ETVanguard Group Inc13G/A7.92%3.94M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Nu Skin Enterprises, Inc. shares.

No Form 144 notices for Nu Skin Enterprises, Inc. are on file.